Comparative Analysis of ERCP and PTBD for Biliary Interventions for Readmission Rates and Patient Outcomes

心理干预 医学 护理部
作者
Daniel Wang,Patrick Chang,Supisara Tintara,Frederick Chang,Jennifer Phan
出处
期刊:Research Square - Research Square
标识
DOI:10.21203/rs.3.rs-4373407/v1
摘要

Abstract Background Endoscopic retrograde cholangiopancreatography (ERCP) and percutaneous transhepatic biliary drainage (PTBD) are interventions used to relieve biliary obstruction. The utility of ERCP compared to PTBD is not fully understood from a utilization outcome standpoint. Our study compares readmission rates and hospitalization outcomes in ERCP and PTBD. Methods Using the National Readmission Database (NRD) 2016–2020, we identified all patients with an ERCP or PTBD completed during admission. The study cohort was first analyzed by three weighted study arms including those admitted with cholangitis, biliary/pancreatic malignancy, and choledocholithiasis. Second, we analyzed the cohort by a 1:1, unweighted propensity match. Primary outcome was 30 day, 90 day, and 6 month readmission. Secondary outcomes were readmission/overall mortality, cost, and length of stay. Outcomes were analyzed using multivariate analysis. Results A total of 621,735 admissions were identified associated with 589,796 ERCP and 31,939 PTBD. In the propensity matched cohort, PTBD had a higher readmission rate at 30 days (20.38% vs 13.71% p < 0.0001), 90 days (14.63% vs 13.14%, p < 0.0001), but lower rate at 6 months (8.50% vs 9.67%, p = 0.0003). Secondary outcomes included increased PTBD-associated hospital length of stay (9.01 days vs 6.74 days, p < 0.0001), hospitalization cost ($106,947.97 vs $97602.25, p < 0.0001), and overall mortality (6.86% vs 4.35%, p < 0.0001). No major differences were found for mortality among readmissions at 30 days (7.19% vs 6.88%, p = 0.5382), 90 day (6.82% vs 6.51%, p = 0.5612), and 6 months (5.08% vs 5.91%, p = 0.1744). Conclusions Although both ERCP and PTBD had no major differences in mortality among readmissions, patients who had ERCP had lower readmission rates, length of stay, and overall mortality. While ERCP may be associated with a health systems benefit in routine indications, a multi-disciplinary approach may be of benefit for complex cases.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
结实山水完成签到 ,获得积分10
刚刚
Tici完成签到,获得积分10
刚刚
冬狩完成签到,获得积分10
刚刚
洁净的寒安完成签到,获得积分10
刚刚
刘星宇完成签到,获得积分10
2秒前
2秒前
2秒前
头疼完成签到,获得积分10
3秒前
量子星尘发布了新的文献求助10
3秒前
3秒前
4秒前
4秒前
4秒前
Zoe完成签到 ,获得积分10
4秒前
英姑应助白衣采纳,获得10
4秒前
eagle发布了新的文献求助10
4秒前
明亮夏旋完成签到,获得积分10
6秒前
6秒前
7秒前
en发布了新的文献求助10
7秒前
7秒前
完美夜春完成签到 ,获得积分10
8秒前
Zhidong Wei发布了新的文献求助10
8秒前
老鼠想吃猫完成签到,获得积分10
9秒前
10秒前
勤奋流沙完成签到 ,获得积分10
10秒前
小白应助gbx采纳,获得10
10秒前
科研通AI2S应助梧桐采纳,获得10
10秒前
10秒前
yinhe关注了科研通微信公众号
11秒前
笔记本完成签到,获得积分0
11秒前
Rainbow完成签到,获得积分10
11秒前
量子星尘发布了新的文献求助10
12秒前
li完成签到 ,获得积分10
12秒前
火星上的百川完成签到,获得积分10
12秒前
RIPCCCP发布了新的文献求助10
13秒前
斯文败类应助zhui采纳,获得10
13秒前
Lee发布了新的文献求助10
13秒前
李欣华完成签到,获得积分10
15秒前
巫马夜安完成签到,获得积分10
15秒前
高分求助中
Production Logging: Theoretical and Interpretive Elements 2700
Neuromuscular and Electrodiagnostic Medicine Board Review 1000
Statistical Methods for the Social Sciences, Global Edition, 6th edition 600
こんなに痛いのにどうして「なんでもない」と医者にいわれてしまうのでしょうか 510
Walter Gilbert: Selected Works 500
An Annotated Checklist of Dinosaur Species by Continent 500
岡本唐貴自伝的回想画集 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 物理 生物化学 纳米技术 计算机科学 化学工程 内科学 复合材料 物理化学 电极 遗传学 量子力学 基因 冶金 催化作用
热门帖子
关注 科研通微信公众号,转发送积分 3661303
求助须知:如何正确求助?哪些是违规求助? 3222367
关于积分的说明 9745047
捐赠科研通 2931980
什么是DOI,文献DOI怎么找? 1605350
邀请新用户注册赠送积分活动 757854
科研通“疑难数据库(出版商)”最低求助积分说明 734569